Coloplast A/S

Coloplast A/S

CLPBF

$62.81

Updated: 24/09/2026, 16:13:15

Market Cap
$13.02B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
DK
Stock valuation chart
One-year closing share-price history for CLPBF
Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

USD
OTC
CEO: Gavin Wood
Employees: 16,907
https://www.coloplast.com
Asset Summaries
Latest generated summaries for CLPBF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for CLPBF.
Share price
$62.81
Market cap
$13.02B
Exchange
OTC
Currency
USD
CEO
Gavin Wood
Employees
16,907
IPO date
09/08/2000
Beta
0.553
Last dividend
$0.00
Day range
$62.81 – $65.16
52-week range
$56.81 – $95.43
1-day performance
0.00%
1-year performance
10.56%
Current drawdown (1Y)
-34.18%
CIK
N/A
CUSIP
N/A
ISIN
DK0060448595
Created
07/12/2025, 03:21:11
Last update
24/09/2026, 16:13:15

Track Coloplast A/S with an AI analyst

See which prediction-market events move CLPBF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to CLPBF from your Railway `news_articles` table.

No news found for this symbol.